Intra-individual Cross-over Efficacy Evaluation of Dotarem-Enhanced MRI Compared to Gadovist/ Gadavist-Enhanced MRI in the Diagnosis of Brain Tumors
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2017
Price : $35 *
At a glance
- Drugs Gadoterate-meglumine (Primary) ; Gadobutrol
- Indications Brain cancer
- Focus Diagnostic use
- Acronyms REMIND
- Sponsors Guerbet
- 24 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.